Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study

<div>Cumulative incidence of ESRD in patients with liver cirrhosis that was analyzed using the modified log-rank test with death adjusted as a competing risk event.</div>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study 

Figure 2 | Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study 